Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials

References

• Warwick HM, Salkovskis PM. Hypochondriasis. Behav Res Ther. 1990;28:105–117. doi: 10.1016/0005-7967(90)90023-C
   PubMed Web of Science ®Google Scholar
• Axelsson E, Hedman-Lagerlöf E. Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter? J Psychosom Res. 2023;165:111133. doi: 10.1016/j.jpsychores.2022.111133
   PubMed Web of Science ®Google Scholar
• Stein DJ, Kogan CS, Atmaca M, et al. The classification of obsessive-compulsive and related disorders in the ICD-11. J Affect Disord. 2016;190:663–674. doi: 10.1016/j.jad.2015.10.061
   PubMed Web of Science ®Google Scholar
• Olatunji BO, Deacon BJ, Abramowitz JS. Is hypochondriasis an anxiety disorder? Br J Psychiatry. 2009;194(6):481–482. doi: 10.1192/bjp.bp.108.061085
   PubMed Web of Science ®Google Scholar
• Abramowitz JS, Moore EL. An experimental analysis of hypochondriasis. Behav Res Ther. 2007;45:413–424. doi: 10.1016/j.brat.2006.04.005
   PubMed Web of Science ®Google Scholar
• Leonidou C, Panayiotou G. How do illness-anxious individuals process health-threatening information? A systematic review of evidence for the cognitive-behavioral model. J Psychosom Res. 2018;111:100–115. doi: 10.1016/j.jpsychores.2018.06.001
   PubMed Web of Science ®Google Scholar
• Weck F, Richtberg S, Neng J. Epidemiology of hypochondriasis and health anxiety: Comparison of different diagnostic criteria. Curr Psychiatry Rev. 2014;10(1):14–23. doi: 10.2174/1573400509666131119004444
   Google Scholar
• Olde Hartman TC, Borghuis MS, Lucassen PL, et al. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res. 2009;66:363–377. doi: 10.1016/j.jpsychores.2008.09.018
   PubMed Web of Science ®Google Scholar
• Sunderland M, Newby JM, Andrews G. Health anxiety in Australia: prevalence, comorbidity, disability and service use. Br J Psychiatry. 2013;202(1):56–61. doi: 10.1192/bjp.bp.111.103960
   PubMed Web of Science ®Google Scholar
• Norbye AD, Abelsen B, Førde OH, et al. Health anxiety is an important driver of healthcare use. BMC Health Serv Res. 2022;22. doi: 10.1186/s12913-022-07529-x.
   PubMed Web of Science ®Google Scholar
• Axelsson E, Hedman-Lagerlöf E. Cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes. Expert Rev Pharmacoecon Outcomes Res. 2019;19(6):663–676. doi: 10.1080/14737167.2019.1703182
   PubMed Web of Science ®Google Scholar
• Vincent C. Understanding and responding to adverse events. N Engl J Med. 2003;348(11):1051–1056. doi: 10.1056/NEJMhpr020760
   PubMed Web of Science ®Google Scholar
• Rozental A, Kottorp A, Boettcher J, et al. Negative effects of psychological treatments: An Exploratory Factor analysis of the negative effects questionnaire for Monitoring and reporting adverse and unwanted events. PLoS One. 2016;11(6):e0157503. doi: 10.1371/journal.pone.0157503
   PubMed Web of Science ®Google Scholar
• Moritz S, Fieker M, Hottenrott B, et al. No pain, no gain? Adverse effects of psychotherapy in obsessive–compulsive disorder and its relationship to treatment gains. J Obsessive Compuls Relat Disord. 2015;5:61–66. doi: 10.1016/j.jocrd.2015.02.002
   Web of Science ®Google Scholar
• Rozental A, Magnusson K, Boettcher J, et al. For better or worse: An individual patient data meta-analysis of deterioration among participants receiving Internet-based cognitive behavior therapy. J Consult Clin Psychol. 2017;85(2):160–177. doi: 10.1037/ccp0000158
   PubMed Web of Science ®Google Scholar
• Swift JK, Greenberg RP. Premature discontinuation in adult psychotherapy: a meta-analysis. J Consult Clin Psychol. 2012;80(4):547–559. doi: 10.1037/a0028226
   PubMed Web of Science ®Google Scholar
• Fernandez-Arias I, Garcia-Fernandez G, Bernaldo-de-Quiros M, et al. Premature termination of psychological treatment for anxiety disorders in a clinical setting. Psicothema. 2016;28(3):241–246. doi: 10.7334/psicothema2015.201
   PubMed Web of Science ®Google Scholar
• Santana L, Fontenelle LF. A review of studies concerning treatment adherence of patients with anxiety disorders. Patient Prefer Adherence. 2011;5:427–439. doi: 10.2147/PPA.S23439
   PubMed Web of Science ®Google Scholar
• Gersh E, Hallford DJ, Rice SM, et al. Systematic review and meta-analysis of dropout rates in individual psychotherapy for generalized anxiety disorder. J Anxiety Disord. 2017;52:25–33. doi: 10.1016/j.janxdis.2017.10.001
   PubMed Web of Science ®Google Scholar
• Swift JK, Greenberg RP. A treatment by disorder meta-analysis of dropout from psychotherapy. J Psychother Integr. 2014;24(3):193–207. doi: 10.1037/a0037512
   Google Scholar
• Bentley KH, Cohen ZD, Kim T, et al. The Nature, Timing, and symptom Trajectories of dropout from Transdiagnostic and Single-diagnosis cognitive-behavioral therapy for anxiety disorders. Behav Ther. 2021;52(6):1364–1376. doi: 10.1016/j.beth.2021.03.007
   PubMed Web of Science ®Google Scholar
• Fernandez D, Vigo D, Sampson NA, et al. Patterns of care and dropout rates from outpatient mental healthcare in low-, middle- and high-income countries from the World health Organization’s World Mental health Survey Initiative. Psychol Med. 2021;51(12):2104–2116. doi: 10.1017/S0033291720000884
   PubMed Web of Science ®Google Scholar
• Johnco C, McGuire JF, Roper T, et al. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder. Depress Anxiety. 2020;37(5):407–417. doi: 10.1002/da.22978
   PubMed Web of Science ®Google Scholar
• Ong CW, Clyde JW, Bluett EJ, et al. Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say? J Anxiety Disord. 2016;40:8–17. doi: 10.1016/j.janxdis.2016.03.006
   PubMed Web of Science ®Google Scholar
• Bisby MA, Karin E, Hathway T, et al. A meta-analytic review of randomized clinical trials of online treatments for anxiety: Inclusion/exclusion criteria, uptake, adherence, dropout, and clinical outcomes. J Anxiety Disord. 2022;92:102638. doi: 10.1016/j.janxdis.2022.102638
   PubMed Web of Science ®Google Scholar
• Aderka IM, Anholt GE, van Balkom AJ, et al. Differences between early and late drop-outs from treatment for obsessive-compulsive disorder. J Anxiety Disord. 2011;25:918–923. doi: 10.1016/j.janxdis.2011.05.004
   PubMed Web of Science ®Google Scholar
• Bennemann B, Schwartz B, Giesemann J, et al. Predicting patients who will drop out of out-patient psychotherapy using machine learning algorithms. Br J Psychiatry. 2022;220:1–10. doi: 10.1192/bjp.2022.17
   Web of Science ®Google Scholar
• Zimmermann D, Rubel J, Page AC, et al. Therapist effects on and predictors of non-Consensual dropout in psychotherapy. Clin Psychol Psychother. 2017;24:312–321. doi: 10.1002/cpp.2022
   PubMed Web of Science ®Google Scholar
• Hedman E, Axelsson E, Andersson E, et al. Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trial. Br J Psychiatry. 2016;209:407–413. doi: 10.1192/bjp.bp.116.181396
   PubMed Web of Science ®Google Scholar
• Axelsson E, Andersson E, Ljótsson B, et al. Effect of Internet vs face-to-face cognitive behavior therapy for health anxiety: A randomized Noninferiority clinical trial. JAMA Psychiatry. 2020;77(9):915–924. doi: 10.1001/jamapsychiatry.2020.0940
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Bramer WM, Giustini D, de Jonge GB, et al. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104(3):240–243. doi: 10.3163/1536-5050.104.3.014
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4
   PubMed Web of Science ®Google Scholar
• Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(3):223–228. doi: 10.1016/j.jpsychores.2013.06.033
   PubMed Web of Science ®Google Scholar
• R core Team. R: a Language and Environment for statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2016. https://www.R-project.org/
   Google Scholar
• Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48. doi: 10.18637/jss.v036.i03
   Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463. doi: 10.1111/j.0006-341X.2000.00455.x
   PubMed Web of Science ®Google Scholar
• Junqueira DR, Zorzela L, Golder S, et al. CONSORT harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. BMJ. 2023;381.
   PubMedGoogle Scholar
• Axelsson E, Andersson E, Ljótsson B, et al. The health preoccupation diagnostic interview: inter-rater reliability of a structured interview for diagnostic assessment of DSM-5 somatic symptom disorder and illness anxiety disorder. Cogn Behav Ther. 2016;45:259–269. doi: 10.1080/16506073.2016.1161663
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33.
   PubMed Web of Science ®Google Scholar
• Hedman-Lagerlöf E, Axelsson E. Cognitive behavioral therapy for health anxiety. In: Hedman-Lagerlöf E, editor. The Clinician's Guide to Treating Health Anxiety: diagnosis, Mechanisms, and Effective Treatment. Cambridge, MA: Academic Press; 2019. 9780128118061.
   Google Scholar
• Furer P, Walker JR. Treatment of hypochondriasis with exposure. J Contemp Psychother. 2005;35(3):251–267. doi: 10.1007/s10879-005-4319-y
   Google Scholar
• Salkovskis PM, Rimes K, Warwick H, et al. The health anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32(5):843–853. doi: 10.1017/S0033291702005822
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Hesser H, Andersson E, et al. Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behav Res Ther. 2014;55:27–39. doi: 10.1016/j.brat.2014.01.007
   PubMed Web of Science ®Google Scholar
• Svanborg P, Åsberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating scale. Acta Psychiatr Scand. 1994;89(1):21–28. doi: 10.1111/j.1600-0447.1994.tb01480.x
   PubMed Web of Science ®Google Scholar
• Leon AC, Olfson M, Portera L, et al. Assessing psychiatric impairment in primary care with the Sheehan Disability scale. Int J Psychiatry Med. 1997;27(2):93–105. doi: 10.2190/T8EM-C8YH-373N-1UWD
   PubMed Web of Science ®Google Scholar
• Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry. 1972;3(4):257–260. doi: 10.1016/0005-7916(72)90045-6
   Web of Science ®Google Scholar
• Boettcher J, Rozental A, Andersson G, et al. Side effects in Internet-based interventions for social anxiety disorder. Internet Interv. 2014;1(1):3–11. doi: 10.1016/j.invent.2014.02.002
   Google Scholar
• Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12–19. doi: 10.1037/0022-006X.59.1.12
   PubMed Web of Science ®Google Scholar
• Olatunji BO, Etzel EN, Tomarken AJ, et al. The effects of safety behaviors on health anxiety: an experimental investigation. Behav Res Ther. 2011;49:719–728. doi: 10.1016/j.brat.2011.07.008
   PubMed Web of Science ®Google Scholar
• Fallon BA, Basaraba C, Pavlicova M, et al. Differential treatment response between hypochondriasis with and without Prominent somatic symptoms. Front Psychiatry. 2021;12:691703. doi: 10.3389/fpsyt.2021.691703
   PubMed Web of Science ®Google Scholar
• Österman S, Axelsson E, Lindefors N, et al. The 14-item short health anxiety inventory (SHAI-14) used as a screening tool: appropriate interpretation and diagnostic accuracy of the Swedish version. BMC Psychiatry. 2022;22. doi: 10.1186/s12888-022-04367-3.
   PubMed Web of Science ®Google Scholar
• Shabahang R, Aruguete MS, McCutcheon L. Video-based cognitive-behavioral intervention for COVID-19 anxiety: a randomized controlled trial. Trends Psychiatry Psychother. 2021;43:141–150. doi: 10.47626/2237-6089-2020-0056
   PubMedGoogle Scholar
• Bourgault-Fagnou MD, Hadjistavropoulos HD. A randomized trial of two forms of cognitive behaviour therapy for an older adult population with subclinical health anxiety. Cogn Behav Ther. 2013;42:31–44. doi: 10.1080/16506073.2012.717302
   PubMed Web of Science ®Google Scholar
• Warwick HM, Clark DM, Cobb AM, et al. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry. 1996;169:189–195. doi: 10.1192/bjp.169.2.189
   PubMed Web of Science ®Google Scholar
• Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis: A randomised controlled trial. Br J Psychiatry. 1998;173(3):218–225. doi: 10.1192/bjp.173.3.218
   PubMedGoogle Scholar
• Visser S, Bouman TK. The treatment of hypochondriasis: Exposure plus response prevention vs cognitive therapy. Behav Res Ther. 2001;39:423–442. doi: 10.1016/S0005-7967(00)00022-X
   PubMed Web of Science ®Google Scholar
• Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004;291(12):1464–1470. doi: 10.1001/jama.291.12.1464
   PubMed Web of Science ®Google Scholar
• Buwalda FM, Bouman TK, van Duijn MA. Psychoeducation for hypochondriasis: a comparison of a cognitive-behavioural approach and a problem-solving approach. Behav Res Ther. 2007;45:887–899. doi: 10.1016/j.brat.2006.08.004
   PubMed Web of Science ®Google Scholar
• Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007;164:91–99. doi: 10.1176/ajp.2007.164.1.91
   PubMed Web of Science ®Google Scholar
• Seivewright H, Green J, Salkovskis P, et al. Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry. 2008;193:332–337. doi: 10.1192/bjp.bp.108.052936
   PubMed Web of Science ®Google Scholar
• Hedman E, Andersson G, Andersson E, et al. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2011;198:230–236. doi: 10.1192/bjp.bp.110.086843
   PubMed Web of Science ®Google Scholar
• Sørensen P, Birket-Smith M, Wattar U, et al. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011;41(2):431–441. doi: 10.1017/S0033291710000292
   PubMed Web of Science ®Google Scholar
• Bovell CV. Randomized controlled Feasibility trial of a self-Help book for health anxiety. Regina, Canada: University of Regina; 2012.
   Google Scholar
• Hedman E, Axelsson E, Görling A, et al. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014;205:307–314. doi: 10.1192/bjp.bp.113.140913
   PubMed Web of Science ®Google Scholar
• Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet. 2014;383(9913):219–225. doi: 10.1016/S0140-6736(13)61905-4
   PubMed Web of Science ®Google Scholar
• Weck F, Neng JM, Richtberg S, et al. Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): A randomized controlled trial. J Consult Clin Psychol. 2015;83:665–676. doi: 10.1037/ccp0000013
   PubMed Web of Science ®Google Scholar
• de Meza Skjernov M. Group cognitive behaviour therapy for severe health anxiety: a randomised controlled trial. Copenhagen, Denmark: University of Copenhagen; 2017.
   Google Scholar
• Fallon BA, Ahern DK, Pavlicova M, et al. A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis. Am J Psychiatry. 2017;174(8):756–764. doi: 10.1176/appi.ajp.2017.16020189
   PubMed Web of Science ®Google Scholar
• Newby JM, Smith J, Uppal S, et al. Internet-based cognitive behavioral therapy versus psychoeducation control for illness anxiety disorder and somatic symptom disorder: A randomized controlled trial. J Consult Clin Psychol. 2018;86(1):89–98. doi: 10.1037/ccp0000248
   PubMed Web of Science ®Google Scholar
• Morriss R, Patel S, Malins S, et al. Clinical and economic outcomes of remotely delivered cognitive behaviour therapy versus treatment as usual for repeat unscheduled care users with severe health anxiety: a multicentre randomised controlled trial. BMC Med. 2019;17(1):16. doi: 10.1186/s12916-019-1253-5
   PubMedGoogle Scholar
• Hoffmann D, Rask CU, Hedman-Lagerlöf E, et al. Efficacy of internet-delivered acceptance and commitment therapy for severe health anxiety: results from a randomized, controlled trial. Psychol Med. 2020;51:1–11. doi: 10.1017/S0033291720001312
   Web of Science ®Google Scholar
• Hedman E. Therapist guided internet delivered cognitive behavioural therapy. BMJ. 2014;348(mar10 2):g1977. doi: 10.1136/bmj.g1977
   PubMedGoogle Scholar
• Almeida L, Kashdan TB, Nunes T, et al. Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. Eur J Clin Pharmacol. 2008;64(6):575–582. doi: 10.1007/s00228-008-0468-8
   PubMed Web of Science ®Google Scholar
• Newby JM, Haskelberg H, Hobbs MJ, et al. The effectiveness of internet-delivered cognitive behavioural therapy for health anxiety in routine care. J Affect Disord. 2020;264:535–542. doi: 10.1016/j.jad.2019.11.087
   PubMed Web of Science ®Google Scholar
• Olatunji BO, Deacon BJ, Abramowitz JS. The Cruelest Cure? Ethical Issues in the Implementation of exposure-based treatments. Cogn Behav Pract. 2009;16:172–180. doi: 10.1016/j.cbpra.2008.07.003
   Web of Science ®Google Scholar
• Richard DCS, Gloster AT. Chapter 18 - exposure therapy has a public relations problem: a dearth of litigation amid a wealth of concern. In: Richard D Lauterbach D, editors. Handbook of exposure therapies. Academic Press; 2007. p. 409–425. doi: 10.1016/B978-012587421-2/50019-3
   Google Scholar
• Farrell NR, Deacon BJ, Kemp JJ, et al. Do negative beliefs about exposure therapy cause its suboptimal delivery? An experimental investigation. J Anxiety Disord. 2013;27(8):763–771. doi: 10.1016/j.janxdis.2013.03.007
   PubMed Web of Science ®Google Scholar
• Trivasse H, Webb TL, Waller G. A meta-analysis of the effects of training clinicians in exposure therapy on knowledge, attitudes, intentions, and behavior. Clin Psychol Rev. 2020;80:101887. doi: 10.1016/j.cpr.2020.101887
   PubMed Web of Science ®Google Scholar
• Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav. 2019;97:111–121. doi: 10.1016/j.addbeh.2018.08.027
   PubMed Web of Science ®Google Scholar
• Danborg PB, Valdersdorf M, Gotzsche PC. Long-term harms from previous use of selective serotonin reuptake inhibitors: a systematic review. Int J Risk Saf Med. 2019;30:59–71. doi: 10.3233/JRS-180046
   PubMed Web of Science ®Google Scholar
• Kelly K, Posternak M, Alpert JE. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci. 2008;10:409–418. doi: 10.31887/DCNS.2008.10.4/kkelly
   PubMedGoogle Scholar
• Rozental A, Kottorp A, Forsstrom D, et al. The negative effects questionnaire: psychometric properties of an instrument for assessing negative effects in psychological treatments. Behav Cogn Psychother. 2019;47:559–572. doi: 10.1017/S1352465819000018
   PubMed Web of Science ®Google Scholar
• Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109. doi: 10.1016/j.jclinepi.2007.03.012
   PubMed Web of Science ®Google Scholar